Gattex Goes To Advisory Panel With Positive Confirmatory Trial Data
This article was originally published in The Pink Sheet Daily
Executive Summary
Clinical data for teduglutide, which goes before the Gastrointestinal Drugs Advisory Committee Oct. 16 as the first drug for treating short bowel syndrome, includes positive results from a confirmatory trial and mixed results from the initial study.